ScholarWorks@Hanyang University: Kim, Tae Hyung

Detailed Information

Kim, Tae Hyung (김태형)

서울 의과대학 (DEPARTMENT OF INTERNAL MEDICINE)

Research Area: 호흡기알레르기내과

Tel 031-560-2243
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

COPD:17||Asthma:15||chronic obstructive pulmonary disease:13||Chronic obstructive pulmonary disease:13||Exacerbation:9||epidemiology:8||bronchiectasis:7||emphysema:6||Mortality:4||mortality:4||Pulmonary Disease, Chronic Obstructive:4||interstitial lung disease:4||Acute exacerbation:4||exacerbation:4||Chronic Obstructive:4||risk:4||Tuberculosis:4||chronic obstructive:4||Pulmonary Disease:4||COVID19:4||Polymorphism:3||Diffusing capacity:3||Korea:3||Lung volume:3||Education:3||Bronchiectasis:3||Chronic Obstructive Pulmonary Disease:3||Colchicine:3||prevalence:3||prognosis:3||exhaled nitric oxide:3||Paragonimiasis:3||tuberculosis:3||comorbidity:3||Pulmonary disease:3||lung cancer:3||IL1Ra:3||Emphysema:3||acute exacerbation:3||Reference equation:3||Carcinoma:3||treatment outcome:2||Malignant effusion:2||Pulmonary disease, chronic obstructive:2||Massive pleural effusion:2||Emergency department visit:2||Air pollution:2||idiopathic pulmonary fibrosis:2||Etiology:2||Respiratory Function Tests:2||Multiple Pulmonary Nodules:2||Idiopathic Pulmonary Fibrosis:2||Exercise:2||FEV1:2||Cystic:2||Scrub typhus.:2||Atopic dermatitis:2||asthma:2||Inhaled corticosteroid:2||Bronchodilator agents:2||bacteria:2||biomarker:2||Allergic rhinitis:2||body mass index:2||Interstitial lung disease:2||Diffusing capacity.:2||chest CT:2||chronic bronchitis:2||Spirometry:2||physical activity:2||Chronic obstructive pulmonary disease (COPD):2||Leptospirosis:2||cohort study:2||Survival:2||Lower limit of normal:2||pulmonary disease:2||pulmonary fibrosis:2||quality of life:2||Computed tomography:2||Therapeutics:2||Thymoma.:2||risk factors:2||Ectopic:2||diffusing capacity:2||Prognosis:2||disease severity:2||Blood eosinophil:2||sixminute walk test:2||Tuberculous pleurisy.:2||MAPK.:2||symptoms:2||Eosinophils:1||Exercise capacity:1||Exertional desaturation:1||Fat embolism syndrome:1||Fat globules:1||Fibromatosis:1||Forced Expiratory Volume:1||Forced expiratory volumes:1||Fossil fuels:1||GOLD 2014:1||GOLD 2017:1||Generalized edema:1||Genetic:1||Genetic association:1||Glucocorticoids:1||Group A:1||Guideline:1||Guidelines:1||Handheld spirometry:1||Health surveys:1||Hemoptysis:1||Histology:1||Hospitalization:1||Humanized:1||Hyperinflation:1||Hyperuricemia:1||IL25:1||Immunocompetence:1||Indacaterol/glycopyrronium:1||Indoor air:1||Inflammation:1||Influenza B virus:1||Inhalant allergen:1||Inhaled long acting bronchodilator:1||Inhaled therapy:1||Inhaler:1||Inspiratory capacity:1||Invasive pulmonary aspergillosis:1||Iron:1||Korean:1||LABA/LAMA combination:1||Leukemia:1||Lung Disease:1||Lung cancer:1||Lung function:1||Lung volume measurements:1||Lymphocytic:1||Lymphocytic interstitial pneumonia:1||MAPK:1||Metered Dose Inhalers:1||Mexiletine:1||Microbiology:1||Monoclonal:1||Multidrugresistant tuberculosis:1||Mycobacterial disease:1||Mycobacterium tuberculosis:1||NIOX MINO:1||NOA280i:1||Nationwide Registry:1||Never smoker:1||Nicotine:1||NonSmall Cell Lung:1||NonSmallCell Lung:1||Nonsmall Cell Lung:1||Nontuberculosis mycobacterial (NTM) infection:1||Nuclearfactor kappa B:1||Observational Study:1||Occupational exposure:1||Optimistic bias:1||Outcome:1||Paint:1||Paraproteinemias:1||Parasitic lung diseases:1||Pharmacogenetics:1||Phenotype:1||Physicians, Primary Care:1||Plasmacytoma:1||Pleural Effusion:1||PositronEmission Tomography:1||Predicted Values:1||Prediction:1||Prevention &:1||Primary Health Care:1||Pulmonary Atelectasis:1||Pulmonary Diffusing Capacity:1||Pulmonary Eosinophilia:1||Pulmonary Tuberculosis:1||Quality of life:1||Questionnaire:1||Questionnaires:1||RANTES:1||Recurrence:1||Reference Equations:1||Residual Volume:1||Respiration:1||Respiratory allergy:1||Respiratory failure:1||Rheumatoid:1||Rheumatoid arthritis:1||Rhinovirus:1||Risk Factors:1||SABA:1||Sarcoidosis:1||Secondhand smoke:1||SeptiFast test:1||Sixminute walk distance:1||Small Cell Lung Carcinoma:1||Smartphone:1||Smokers:1||Smoking:1||Smoking cessation:1||Solitary fibrous tumor of pleura:1||South Korea:1||Specific IgE:1||St. George&apos:1||Stomach Neoplasms:1||Subtype:1||Surveys:1||Symptom Flare Up:1||TNF inhibitor:1||TSLP:1||Telesonography:1||Thorax:1||Tiotropium:1||Tomography, Xray computed:1||Total Lung Capacity:1||Total lung capacity:1||Treatment:1||Treatment Response:1||Tumor Necrosis Factoralpha:1||Upper Extremity Deep Vein Thrombosis:1||Uterine leiomyoma:1||Vaccination:1||Validation:1||Viewing of clinical imaging:1||Virology:1||Vitamin D deficiency:1||Wnt/betacatenin pathway:1||Wnt7a:1||adipokines:1||adiposederived hormones:1||adiposity:1||adults:1||adverse reaction:1||adverse reactions:1||age:1||air pollution:1||airway inflammation:1||alarmin:1||anemia:1||animal model:1||annual lung function decline:1||antibody:1||antibodycoated bacteria test:1||association:1||asthma exacerbation:1||atopy:1||betaagonist:1||bleomycin:1||bronchial asthma:1||bronchial hyperresponsiveness:1||bronchiectasis health questionnaire:1||bronchodilators:1||chronic:1||chronic airflow obstruction:1||chronic obstructive lung disease:1||chronic obstructive pulmonary disease (COPD):1||chronic periodontitis:1||clinical epidemiology:1||clinical marker:1||computed tomography:1||control:1||coronavirus disease 2019:1||corticosteroid:1||cough:1||crosssectional studies:1||death:1||dementia:1||depression:1||desquamative interstitial pneumonia:1||diagnostic test:1||disease burden:1||drug susceptibility:1||dyspnea:1||early bactericidal activity:1||echocardiography:1||elderly:1||environmental pollution:1||eosinophils:1||experimental therapeutics:1||extensively drugresistant tuberculosis:1||forced expiratory flow between 25% and 75% of vital capacity:1||frequent exacerbation:1||gastroesophageal reflux:1||gender:1||haemoglobin:1||healthcare workers:1||hyperinflation:1||hyperoxiainduced lung injury:1||hypertension:1||infection:1||influenza:1||inhalers:1||insulinlike growth factor:1||intensive care units:1||internal medicine:1||lipocalin2:1||longacting beta2 agonist:1||longacting muscarinic antagonist:1||lung function:1||lung volume:1||mHealth:1||macrolide:1||mannitol:1||mass spectrometry:1||mobile phone:1||multidrugresistant:1||multiplex polymerase chain reaction:1||nasal nitric oxide:1||neutrophils:1||nitric oxide analyzer:1||nontuberculosis mycobacterium:1||obesity:1||obstructive lung disease:1||occupational exposure:1||outcome:1||outpatients:1||oxazolidinones:1||particulate matter:1||periodontitis:1||periostin:1||pharmacotherapy:1||pneumonia:1||polymerase chain reaction:1||polymorphism:1||population:1||prescription:1||prolonged cough:1||public health:1||pulmonary:1||pulmonary artery pressure:1||quality of life (QoL):1||reference value:1||rehabilitation:1||respiratory virus:1||resting state functional connectivity:1||rheumatic diseases (RDs):1||risk factor:1||s Respiratory Questionnaire:1||salbutamol:1||sedentary behavior:1||severity:1||sex:1||siRNA:1||sinusitis:1||smoking:1||spirometry:1||sputum culture:1||survival rate:1||symptom burden:1||symptom flare up:1||tension pneumothorax:1||treatment:1||treatment efficacy:1||tuberculosis (TB):1||tuberculosis survival rate:1||upper airway cough syndrome:1||urinary:1||urinary desmosines:1||vaccination:1||vaccine:1||vascular dementia:1||virus:1||volumetric computed tomography:1||급성 악화:1||대기오염:1||응급실방문:1||A549 cell:1||천식:1||ABPM:1||Abnormalities:1||Acute Exacerbation:1||Acute kidney injury:1||Acute respiratory failure:1||Adrenergic betaAgonists:1||Aged:1||Aggressive:1||Air:1||Air pollutants:1||Airway Hyperresponsiveness:1||Airway hyperresponsiveness:1||Allergic bronchopulmonary:1||Allergy:1||Alternaria alternate:1||Alzheimer disease:1||Analgesia:1||Anesthesia:1||Antibodies:1||Antifibrotic Agent:1||Antioxidants:1||Antiphospholipid Syndrome:1||Arthritis:1||Artificial:1||Assessment:1||AsthmaCOPD overlap:1||Atopy:1||Awareness:1||BCell:1||BMI:1||Bacteriology:1||Beas2B cell:1||Benign metastasizing leiomyomatosis (BML):1||Benzopyrene:1||Bilirubin:1||Biologic DMARDs:1||Biologic Markers:1||Biomarker:1||Blood culture:1||Body mass index:1||Brain functional magnetic resonance imaging:1||Bronchi:1||Bronchial Asthma:1||Bronchial Provocation Tests:1||Bronchial arteries:1||Bronchitis:1||Bronchoalveolar lavage:1||Bronchopleural fistula:1||Ckit (CD117):1||CHRNA3:1||COPD Assessment Test:1||COPD overlap:1||COPDA:1||COVID19 infection:1||COVID19 vaccination:1||CRHR1:1||Cancer screening:1||Carbon Monoxide:1||Cardiovascular diseases:1||Catheterrelated infections:1||ChAdOx1 nCoV19 vaccine:1||Chest Tubes:1||Chronic:1||Chronic Obstructive Pulmonary Disease Assessment Test:1||Chronic bronchitis:1||Chronic expanding hematoma:1||Chronic obstructive:1||Clinical validation:1||Computed Tomography:1||Confidence intervals:1||Contrast media:1||Corticosteroid:1||Corticosteroids:1||Cotinine:1||Cryptogenic organizing pneumonia:1||Cutaneous infection:1||Cystic adenomatoid malformation of lung, Congenital:1||Dental Technicians:1||Diabetes mellitus:1||Diagnosis:1||Diffusion:1||Disease Management:1||Disease Progression:1||Disease prevention:1||Drug Hypersensitivity:1||Dry Powder Inhalers:1||Ecadherin:1||Embolism:1||Embolization, therapeutic:1||Environmental exposure:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE